Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Epidemiology

  • Chapter
  • First Online:
HIV-associated Hematological Malignancies

Abstract

This chapter addresses epidemiological aspects of HIV-associated hematological malignancies in the combination antiretroviral therapy (cART) era. Before the advent of cART, people with HIV infection or AIDS (PWA) had several hundredfold higher risk of non-Hodgkin’s lymphoma (NHL) and about 10- to 20-fold higher risk of Hodgkin’s lymphoma (HL) than the general population of the same sex and age. Although the incidence of NHL in PWA has fallen markedly in the cART era, it remains remarkably higher than in the general population, while rates and excesses of HL remain substantially unvaried. By contrast, leukemias, multiple myeloma, and other hematological conditions are only slightly more common in HIV settings. In addition to a higher risk of developing hematological malignancies, PWA are also at elevated risk of death than their counterparts in the general population. A persisting, although narrowing, gap in cancer survival between PWA and non-PWA is still observed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.

    Article  Google Scholar 

  2. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51–9.

    Article  CAS  PubMed  Google Scholar 

  3. Biggar RJ, Engels E, Ly S, Kahn A, Schymura MJ, Sackoff J, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr. 2005;39:293–9.

    Article  PubMed  Google Scholar 

  4. Carrieri MP, Pradier C, Piselli P, Piche M, Rosenthal E, Heudier P, et al. Reduced incidence of Kaposi’s sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer. 2003;103:142–4.

    Article  CAS  PubMed  Google Scholar 

  5. Chao C, Xu L, Abrams D, Leyden W, Horberg M, Towner W, et al. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010;24:1765–70.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, Bohlius J, et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 2009;113:5737–42.

    Article  CAS  PubMed  Google Scholar 

  7. Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol. 2015;33:2376–83.

    Article  PubMed  Google Scholar 

  8. Dal Maso L, Rezza G, Zambon P, Tagliabue G, Crocetti E, Vercelli M, et al. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer. 2001;93:430–5.

    Article  CAS  PubMed  Google Scholar 

  9. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphoma and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. 2003;4:110–9.

    Article  PubMed  Google Scholar 

  10. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009;100:840–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Dal Maso L, Suligoi B, Franceschi S, Braga C, Buzzoni C, Polesel J, et al. Survival after cancer in Italian persons with AIDS, 1986–2005: a population-based estimation. J Acquir Immune Defic Syndr. 2014;66:428–35.

    Article  Google Scholar 

  12. Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS. 2010;24:1537–48.

    Google Scholar 

  13. Díez-Martín JL, Balsalobre P, Re A, Michieli M, Ribera JM, Canals C, et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood. 2009;113:6011–4.

    Article  PubMed  Google Scholar 

  14. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187–94.

    Article  CAS  PubMed  Google Scholar 

  15. Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103:416–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Frisch M, Biggar RJ, Engels EA, Goedert JJ, for the AIDS Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736–45.

    Article  CAS  PubMed  Google Scholar 

  17. Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28:2313–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, et al. Temporal Trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst. 2013;105:1221–9.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients a meta-analysis. Lancet. 2007;370:59–67.

    Article  PubMed  Google Scholar 

  20. Harrison KMD, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 States, United States. J Acquir Immune Defic Syndr. 2010;53:124–30.

    Article  PubMed  Google Scholar 

  21. Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995–2008. Infection. 2012;40:627–34.

    Article  CAS  PubMed  Google Scholar 

  22. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100B. A Review of human carcinogenesis. IARC Monogr Eval Carcinog Risks Hum. 2012;100(pt B):1–441.

    Google Scholar 

  23. Krishnan A, Palmer JM, Zaia JA, Tsai NC, Alvarnas J, Forman SJ. HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL). Biol Blood Marrow Transplant. 2010;16:1302–8.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalité 2000 and 2005” survey (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590–8.

    Article  PubMed  Google Scholar 

  25. Marin B, Thiébaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23:1743–53.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30:4111–6.

    Article  PubMed  Google Scholar 

  27. Norden AD, Drappatz J, Wen PY, Claus EB. Survival among patients with primary central nervous system lymphoma, 1973–2004. J Neurooncol. 2011;101:487–93.

    Article  PubMed  Google Scholar 

  28. Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, et al. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009. Eur J Cancer. 2013;49:336–44.

    Article  PubMed  Google Scholar 

  29. Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, et al. Non-Hodgkin’s lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS. 2008;22:301–6.

    Article  PubMed  Google Scholar 

  30. Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al. Cancer incidence in people with AIDS. Int J Cancer. 2010;127:1437–45.

    Article  CAS  PubMed  Google Scholar 

  31. Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C, Ocular Complications of AIDS Research Group. Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors. Clin Infect Dis. 2010;51:947–56.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst. 2015;107(4):dju503.

    Article  PubMed  Google Scholar 

  33. Serraino D, Carbone A, Franceschi S, Tirelli U. Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin’s disease in HIV-infected patients. Italian Cooperative Group on AIDS and Tumours. Eur J Cancer. 1993;29A:1948–50.

    Article  CAS  PubMed  Google Scholar 

  34. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer. 2007;43:2117–23.

    Article  PubMed  Google Scholar 

  35. Serraino D, De Paoli A, Zucchetto A, Pennazza S, Bruzzone S, Spina M, et al. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer Epidemiol. 2010;34:257–61.

    Article  PubMed  Google Scholar 

  36. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer. 1997;79:1004–8.

    Article  CAS  PubMed  Google Scholar 

  37. Serraino D, Zucchetto A, Suligoi B, Bruzzone S, Camoni L, Boros S, et al. Survival after AIDS diagnosis in Italy, 1999–2006: a population-based study. J Acquir Immune Defic Syndr. 2009;52:99–105.

    Article  PubMed  Google Scholar 

  38. Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, Hall HI, et al. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992–2009. Cancer Epidemiol Biomarkers Prev. 2013;22:1069–78.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Shiels MS, Koritzinsky EH, Clarke CA, Suneja G, Morton LM, Engels EA. Prevalence of HIV infection among U.S. Hodgkin lymphoma cases. Cancer Epidemiol Biomarkers Prev. 2014;23:274–81.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–62.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis. 2010;51:957–62.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Spagnuolo V, Travi G, Galli L, Cossarini F, Guffanti M, Gianotti N, et al. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study. Cancer. 2013;119:2710–9.

    Article  PubMed  Google Scholar 

  43. Van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, et al. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS. 2009;23:2183–90.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Zucchetto A, Suligoi B, De Paoli A, et al. Excess mortality for non- AIDS-defining cancers among people with AIDS. Clin Infect Dis. 2010;51:1099–101.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Epidemiology and Biostatistics, CRO Aviano National Cancer Institute, IRCCS, via F. Gallini, 2, Aviano, PN, 33081, Italy

    Diego Serraino & Luigino Dal Maso

Authors
  1. Diego Serraino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luigino Dal Maso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diego Serraino .

Editor information

Editors and Affiliations

  1. Department of Hematology and Oncology, Red Cross Hospital, Uni of Munich, Munich, Germany

    Marcus Hentrich

  2. Dept. of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

    Stefan K. Barta

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Serraino, D., Dal Maso, L. (2016). Epidemiology. In: Hentrich, M., Barta, S. (eds) HIV-associated Hematological Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-26857-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26857-6_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26855-2

  • Online ISBN: 978-3-319-26857-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation